Observational studyDiabetes, obesity & metabolism2025
Social determinants of health and progression to cardio-renal-metabolic multimorbidity and mortality in people with prediabetes: A prospective cohort study.
Observational study in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrating social and cardiometabolic risk factors in predicting cardiometabolic multimorbidity: a Bayesian model development and internal validation in Swedish middle-aged adults.Scientific reports · 2026Article
- Accelerometer-derived "weekend warrior" physical activity pattern and trajectory of cardio-renal-metabolic multimorbidity: a multi-state analysis in the UK Biobank.BMC public health · 2026Article
- Social determinants of health and progression to cardio-renal-metabolic multimorbidity and mortality in people with prediabetes: A prospective cohort study.Diabetes, obesity & metabolism · 2025Observational
- Association of the triglyceride-glucose index and its combination with obesity indices with cardio-renal-metabolic multimorbidity: two decades of follow-up in the Tehran Lipid and Glucose Study.Cardiovascular diabetology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsSocial determinants of health (SDHs) have been increasingly recognised as upstream drivers of preventable health disparities. However, it is unclear what the role of SDHs is in the whole progression of prediabetes. We aimed to delineate the impact of SDHs on the progression from prediabetes to subsequent cardio-renal-metabolic disease (CRMD), cardio-renal-metabolic multimorbidity (CRMM) and mortality. MATERIALS AND
methods37 098 participants with prediabetes and free of any CRMD (i.e., type 2 diabetes, cardiovascular disease and chronic kidney disease [CKD]) at baseline from the UK Biobank were included. A combined SDH score was assessed by a sum of 17 items including financial, education, healthcare, neighbourhood, and social domains, and was categorised into favourable, medium, and unfavourable groups by tertile. Outcomes included first CRMD, CRMM (the coexistence of at least two CRMDs) and death during follow-up. Five transition paths were considered, and multistate models were performed.
resultsCompared with the favourable SDH group, the unfavourable SDH group consistently showed elevated risks for different transition stages, except for the CRMM-to-death transition. Lifestyle partially mediated the associations, while the mediation proportions at each stage explained less than 20%. Among disease-specific associations, unfavourable SDHs disproportionally increased the risks of three CRMDs, with the highest risk observed for the CKD-to-death transition (hazard ratio = 2.22, 95% confidence interval: 1.16-4.26).
conclusionsUnfavourable SDHs were associated with increased risks of progression from prediabetes. Resource allocation and lifestyle promotion should be prioritised for those with unfavourable SDHs to mitigate disparities in progression to CRMM and death in diabetes care, especially in the early disease stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.